Deutsche Bank’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Deutsche Bank's HRMY Position: Q3 2026 in Review
Deutsche Bank reduced its Harmony Biosciences (HRMY) stake by 53% in Q3 2026, selling an estimated $2.06M and leaving 48,249 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1808.
Deutsche Bank first reported a position in HRMY in Q4 2020 and has held it in 24 quarters since. The position peaked at $12.9M in Q4 2025. 310 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Deutsche Bank held 48,249 shares of Harmony Biosciences worth $1.89M as of Q3 2026.
- Deutsche Bank sold 53,363 Harmony Biosciences shares in Q3 2026, an estimated $2.06M.
- Harmony Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1808 holding.
- Deutsche Bank first reported a position in Harmony Biosciences in Q4 2020 and has held it in 24 quarters since.
- Deutsche Bank's Harmony Biosciences position peaked at $12.9M in Q4 2025.
- 310 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.